Kiora Pharmaceuticals, Inc. (KPRX)

Kiora Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.03	3.79	2.45	5.96	7.85	1.19
Short-Term Investments	19.64	23	-	-	-	-
Cash & Short-Term Investments	20.67	26.79	2.45	5.96	7.85	1.19
Cash Growth	-25.71%	991.47%	-58.85%	-24.06%	562.47%	-68.61%
Accounts Receivable	2.42	0.6	-	-	-	-
Other Receivables	0.7	0.27	2.05	1.37	0.53	0.09
Receivables	3.11	0.87	2.05	1.37	0.53	0.09
Prepaid Expenses	0.96	2.04	0.23	0.34	0.61	0.45
Total Current Assets	24.74	29.71	4.74	7.68	8.99	1.73
Property, Plant & Equipment	0.46	0.06	0.11	0.17	0.28	0.11
Goodwill	-	-	-	-	-	3.63
Other Intangible Assets	6.69	-	0.12	0.14	0.17	0.19
Long-Term Deferred Charges	-	6.69	8.7	10.6	10.6	9.54
Other Long-Term Assets	0.07	0.03	0.05	0.08	0.09	0.1
Total Assets	31.95	36.48	13.71	18.68	20.13	15.3
Accounts Payable	0.28	0.42	0.21	1.01	0.16	0.43
Accrued Expenses	1.62	2.26	1.38	1.84	1.33	1.29
Current Portion of Long-Term Debt	-	-	-	-	-	0.21
Current Portion of Leases	0.14	0.02	0.05	0.11	0.12	0.05
Current Income Taxes Payable	0.92	2.33	-	-	-	-
Other Current Liabilities	0.22	0.98	-	0.32	-	-
Total Current Liabilities	3.19	6.01	1.63	3.27	1.61	1.98
Long-Term Debt	-	-	-	-	-	0.28
Long-Term Leases	0.29	0.03	0.06	-	0.09	0.04
Long-Term Deferred Tax Liabilities	0.49	0.49	0.78	0.69	0.8	0.73
Other Long-Term Liabilities	4.6	4.19	5.13	3.31	3.05	2.55
Total Liabilities	9.82	10.72	7.6	7.27	5.55	5.57
Common Stock	0.27	0.27	0.08	0.02	0	0.06
Additional Paid-In Capital	169.83	169.16	153.19	146.04	135.54	116.78
Retained Earnings	-147.73	-143.38	-146.98	-134.46	-120.88	-107.11
Comprehensive Income & Other	-0.25	-0.28	-0.18	-0.18	-0.09	-0
Total Common Equity	22.13	25.76	6.11	11.41	14.58	9.73
Shareholders' Equity	22.13	25.76	6.11	11.41	14.58	9.73
Total Liabilities & Equity	31.95	36.48	13.71	18.68	20.13	15.3
Total Debt	0.43	0.06	0.11	0.11	0.21	0.57
Net Cash (Debt)	20.24	26.73	2.35	5.86	7.65	0.61
Net Cash Growth	-27.04%	1038.72%	-59.93%	-23.37%	1150.70%	-83.45%
Net Cash Per Share	4.96	6.48	4.36	72.00	285.39	47.93
Filing Date Shares Outstanding	3.43	3	2.92	0.21	0.04	0.02
Total Common Shares Outstanding	3.43	3	0.86	0.2	0.04	0.02
Working Capital	21.55	23.7	3.1	4.41	7.38	-0.26
Book Value Per Share	6.44	8.58	7.14	57.15	414.44	630.41
Tangible Book Value	15.44	25.76	5.99	11.26	14.41	5.9
Tangible Book Value Per Share	4.50	8.58	7.00	56.43	409.64	382.58
Machinery	-	0.01	0.01	0.15	0.16	0.1
Leasehold Improvements	-	-	-	0.02	0.02	0.02

Updated Aug 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q